Psychological Traits of Patients with Central Serous Chorioretinopathy (Literature Review)
https://doi.org/10.18008/1816-5095-2023-2-221-227
Abstract
Central serous chorioretinopathy (CSC) is a polyethological disease. CSC is one of the few eye diseases for which the relationship between the occurrence, course of the disease and patient psychosocial characteristics has been demonstrated including personality traits and the level of external stress factors. Excessive stimulation such as stressful living conditions, exogenous factors and personal predisposition can lead to CSH. The disease often occurs against the background of acute or chronic stress. Patients with central serous chorioretinopathy are characterized by certain personality traits i.e., type A personality, including a tendency to overachievement, competition, perfectionism, and a sthenic desire to maintain professional status. At the same time, insomnia and sleep apnea, depressive and anxiety states, post-traumatic stress disorder and alexithymia, high blood pressure, Helicobacter pylori, autoimmune diseases, psychopharmacological medication, hormone therapy are among the risk factors.
About the Authors
V. A. Shaimova
Academy of Postgraduate Education of the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of Federal Medical‑Biological Agency;
“Center Zreniya” Medical Clinic
Russian Federation
Russian Federation
Shaimova Venera A. - МD, Professor of the Ophthalmology department
Volokolamskoye highway, 91, Moscow, 125371, Russian Federation
Komsomolsky ave., 99D, Chelyabinsk, 454021, Russian Federation
T. G. Kravchenko
Multidisciplinary Center for Laser Medicine
Russian Federation
Russian Federation
Kravchenko Tatyana G. - PhD in Biology, senior researcher
Pobedy ave., 287, Chelyabinsk, 454138, Russian Federation
G. M. Arslanov
Eye Microsurgery Clinic “Happy Look”
Russian Federation
Russian Federation
Arslanov Gleb M. - MD, оphthalmologist
Ligovskiy ave., 52, Saint-Petersburg, 191040, Russian Federation
T. B. Shaimov
“Center Zreniya” Medical Clinic
Russian Federation
Russian Federation
Shaimov Timur B. - PhD, ophthalmologist
Komsomolsky ave., 99D, Chelyabinsk, 454021, Russian Federation
R. B. Shaimov
“Center Zreniya” Medical Clinic
Russian Federation
Russian Federation
Shaimov Ruslan B. - PhD, director, ophthalmologist
Komsomolsky ave., 99D, Chelyabinsk, 454021, Russian Federation
References
1. Wise TN. Psychosomatics: past, present and future. Psychother Psychosom. 2014;83(2):65–69. doi: 10.1159/000356518.
2. Al Jowf GI, Ahmed ZT, Reijnders RA, de Nijs L, Eijssen LMT. To Predict, Prevent, and Manage Post Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers. Int J Mol Sci. 2023;24(6):5238. doi: 10.3390/ijms24065238.
3. Guidi J, Lucente M, Sonino N, Fava G.A. Allostatic Load and Its Impact on Health: A Systematic Review. Psychother Psychosom. 2021;90(1):11–27. doi: 10.1159/000510696.
4. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153(18):2093–2101.
5. Brook A, Elder A, Zalidis S. Psychological aspects of eye disorders. J R Soc Med. 1998;91(5):270–272. doi: 10.1177/014107689809100510.
6. Miller NR. Neuro ophthalmologic manifestations of psychogenic disease. Semin Neurol. 2006;26(3):310–320. doi: 10.1055/s-2006-945517.
7. Arntz A, Ibañez C, Covarrubias T. Unexplained ocular and visual symptoms: The need for a psychosomatic approach in Ophthalmology. Arch Soc Esp Oftalmol (Engl Ed). 2019;94(12):575–578. doi: 10.1016/j.oftal.2019.08.002.
8. Khoo K, Man REK, Rees G, Gupta P, Lamoureux EL, Fenwick EK. The relationship between diabetic retinopathy and psychosocial functioning: a systematic review. Qual Life Res. 2019;28(8):2017–2039. doi: 10.1007/s11136-019-02165-1.
9. Senra H, Ali Z, Aslam T, Patton N. Psychological implications of vitreous opacities — A systematic review. J Psychosom Res. 2022;154:110729. doi: 10.1016/j.jpsychores.2022.110729.
10. Tomita M, Yamamoto N, Nishikawa T, Ohno Matsui K. Predictive factors for comorbid psychiatric disorders and their impact on vision related quality of life in patients with high myopia. Int Ophthalmol. 2014;34(2):171–183. doi: 10.1007/s10792-013-9805-8.
11. Méndez Ulrich JL, Sanz A. Psycho ophthalmology: Contributions of Health psychology to the assessment and treatment of glaucoma. Psychol Health. 2017;32(3):330–342. doi: 10.1080/08870446.2016.1268690.
12. Shaimova VA, Shaimov TB, Shaimov RB, Galin AYu, Goloshchapova ZA, Ryzhkov PK, Fomin AV. Evaluation of YAG laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters. Annals of Ophthalmology. 2018;134(1):56–62 (In Russ.). doi: 10.17116/oftalma2018134156-62.
13. Vitreous floaters: diagnostics, treatment, complications: atlas / ed. by V.A. Shaimova. Saint Petersburg: Chelovek; 2022. 188 p. (In Russ.).
14. Mansour A.M., Hamam R. Operating room central serous chorioretinopathy. SAGE Open Med Case Rep. 2017;5:2050313X17740052. doi: 10.1177/2050313X17740052.
15. Yu J, Xu G, Chang Q, Ye X, Li L, Jiang C, Zhao Q. Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy. J Ophthalmol. 2019;2019:5970659. doi: 10.1155/2019/5970659.
16. Gundlach BS, Tsui I. Post Traumatic Stress Disorder Is a Significant Risk Factor for Central Serous Chorioretinopathy in Male Veterans. Am J Mens Health. 2021;15(5):15579883211034990. doi: 10.1177/15579883211034990.
17. Panova IE, Shaimov TB, Shaimova VA. OCT morphometric and angiographic parallels between different variants of central serous chorioretinopathy. Annals of Ophthalmology 2017;133(2):10–17 (In Russ.). doi: 10.17116/oftalma2017133210 17.
18. Maltsev DS, Kulikov AN, Chhablani J. Clinical Application of Fluorescein Angiography Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2019;50(4):e118–e124. doi: 10.3928/23258160 20190401 16.
19. Koss MJ, Beger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond). 2012;26(2):307–314. doi: 10.1038/eye.2011.282.
20. Liu DT, Fok AC, Chan W, Lai TY, Lam DS. Central serous chorioretinopathy. In: Ryan SJ, Schachat AP, Sadda SR, eds. Retina. 5th ed. London: Elsevier; 2013:1291–1303.
21. van Rijssen TJ, van Dijk EHC, Yzer S, Ohno Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF. Central serous chorioretinopathy: Towards an evidence based treatment guideline. Prog Retin Eye Res. 2019;73:100770. doi: 10.1016/j.preteyeres.2019.07.003.
22. Volodin PL, Doga AV, Ivanova EV, Pismenskaya VA, Kukharskaya YuI, Khrisanfova ES. The Personalized Approach to the Chronic Central Serous Chorioretinopathy Treatment Based on the Navigated Micropulse Laser Technology. Ophthalmology in Russia. 2018;15(4):394–404 (In Russ.). doi: 10.18008/1816-5095-2018-4-394-404.
23. von Graefe A. Ueber centrale recidivierende retinitis. Graefes Arch Clin Exp Ophthalmol. 1866;12:211–215.
24. Fuchs E. Ein Fall von zentraler residivierender syphilitischer Netzhaut Enzundung. Zentralbl Prakt Augenheilkd. 1916;40:105–108 (In German).
25. Kitahara S. Ueber klinische beobachtungen bei der in Japan häufig vorkom menden chorioretinitis centralis serosa. Klin Monatsbl Augenheilkd. 1936;97:345–362 (In German).
26. Horniker E. Klin Monatsbl Augenheilkd. 1937;98:487 (In German).
27. Duke Elder S. Text book of Ophthalmology. St. Louis: C.V. Mosby Company; 1940;3:2592.
28. Bennett G. Central serous retinopathy. Br J Ophthalmol. 1955;39:605-618.
29. Maumenee AE. Symposium: macular diseases, clinical manifestations. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:605-613.
30. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1967:63:587-615.
31. Liew G, Quin G, Gillies MC, Fraser Bell S. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201-214. doi: 10.1111/j.1442-9071.2012.02848.x.
32. Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F. Acute central serous chorioretinopathy: factors influencing episode duration. Retina. 2017;37(10):1905-1915. doi: 10.1097/iae.0000000000001443.
33. Arora S, Sridharan P, Arora T, Chhabra M, Ghosh B. Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy. Clin Exp Optom. 2019;102(1):79-85. doi: 10.1111/cxo.12818.
34. Mrejen S, Balaratnasingam C, Kaden TR, Bottini A, Dansingani K, Bhavsar KV, Yannuzzi NA, Patel S, Chen KC, Yu S, Stoffels G, Spaide RF, Freund KB, Yannuzzi LA. Long term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology. 2019;126(4):576-588. doi: 10.1016/j.ophtha.2018.12.048.
35. Kim RY, Ma GJ, Park WK, Kim M, Park YG, Park YH. Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy. Medicine. 2021;100(34):e26980. doi: 10.1097/MD.0000000000026980.
36. Shiragami C, Takasago Y, Osaka R, Kobayashi M, Ono A, Yamashita A, Hirooka K. Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization. Am J Ophthalmol. 2018;193:80-86. doi: 10.1016/j.ajo.2018.06.009.
37. Chhablani J. Outcomes of treatment of choroidal neovascularization associated with central serous chorioretinopathy with intravitreal antiangiogenic agents. Retina. 2015;35(12)
38. Agliullin DR, Khasanova GR, Abdulaeva EA. Risk Factors for Central Serous Chorioretinopathy (Review of Epidemiological Studies). Ophthalmology in Russia. 2019;16(4):427-432 (In Russ.). doi: 10.18008/1816-5095-2019-4-427-432.
39. Conrad R, Geiser F, Kleiman A, Zur B, Karpawitz Godt A. Temperament and character personality profile and illness related stress in central serous chorioretinopathy. Scientific World Journal. 2014;2014:631687. doi: 10.1155/2014/631687.
40. Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case control study. Curr Eye Res. 2017;42(7):1069-1073. doi: 10.1080/02713683.2016.
41. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S; Central serous chorioretinopathy case control study group. Risk factors for central serous chorioretinopathy: a case control study. Ophthalmology. 2004;111(2):244-249. doi: 10.1016/j.ophtha.2003.09.024.
42. Agliullin DR, Khasanova GR, Abdulaeva EA, Kagirova LR. Risk Factors for Central Serous Chorioretinopathy: A Case Control Study. Medicine. 2020;8(2):81-93 (In Russ.). doi: 10.29234/2308-9113-2020-8-2-81-93.
43. Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta analysis. Retina. 2016;36(1):9-19. doi: 10.1097/IAE.0000000000000837.
44. Cotticelli L, Borrelli M, D’Alessio AC, Menzione M, Villani A, Piccolo G, Montella F, Iovene MR, Romano M. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol. 2006;16(2):274-278. doi: 10.1177/112067210601600213.
45. Chhablani J, Cohen FB; Central Serous Chorioretinopathy International Group. Multimodal Imaging Based Central Serous Chorioretinopathy Classification. Ophthalmol Retina. 2020;4(11):1043-1046. doi: 10.1016/j.oret.2020.07.026.
46. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14-33. doi: 10.1038/s41433-018-0158-4.
47. Siedlecki J, Schworm B, Priglinger SG. The pachychoroid disease spectrum and the need for a uniform classification system. Ophthalmol Retina. 2019;3(12):1013-1015. doi: 10.1016/j.oret.2019.08.002.
48. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept source optical coherence tomography. Retina. 2016;36(3):499-516. doi: 10.1097/IAE.0000000000000742.
49. Pandolfo G, Genovese G, Bruno A, Palumbo D, Poli U, Gangemi S, Aragona P, Meduri A. Sharing the same perspective. mental disorders and central serous chorioretinopathy: a systematic review of evidence from 2010 to 2020. Biomedicines. 2021;9(8):1067. doi: 10.3390/biomedicines9081067.
50. van Haalen FM, van Dijk EHC, Andela CD, Dijkman G, Biermasz NR, Pereira AM, Boon CJF. Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy. Acta Ophthalmol. 2019;97(4):e572-e579. doi: 10.1111/aos.13952.
51. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina. 1987;7(2):111-131. doi: 10.1097/00006982-198700720-00009.
52. Conrad R, Weber NF, Lehnert M, Holz FG, Liedtke R, Eter N. Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics. 2007;48(6):489-495. doi: 10.1176/appi.psy.48.6.489.
53. Conrad R, Geiser F, Kleiman A, Zur B, Karpawitz Godt A. Temperament and character personality profile and illness related stress in central serous chorioretinopathy. Scientific World Journal. 2014;2014:631687. doi: 10.1155/2014/631687.
54. Lahousen T, Painold A, Luxenberger W, Schienle A, Kapfhammer HP, Ille R. Psychological factors associated with acute and chronic central serous chorioretinopathy. Nord J Psychiatry. 2016;70(1):24-30. doi: 10.3109/08039488.2015.1041156.
55. Sahin A, Bez Y, Kaya MC, Türkcü FM, Sahin M, Yüksel H. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Semin Ophthalmol. 2014;29(2):73-76. doi: 10.3109/08820538.2013.793728.
56. Shchuko AA, Iur’eva TN, Zlobina AN. Features of psycho emotional state of patients with central serous chorioretinopathy. Annals of Ophthalmology 2017;133(2):70-74. (In Russ.). doi: 10.17116/oftalma2017133270-74.
57. Spahn C, Wiek J, Burger T. Operationalisierte psychodynamische Diagnostik (OPD) bei Patienten mit Chorioretinopathia centralis serosa [Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy]. Psychother Psychosom Med Psychol. 2004;54(2):52-57 (In German). doi: 10.1055/s-2003-812610.
58. Bujarborua D, Borooah S, Dhillon B. Getting serious with retinopathy: approaching an integrated hypothesis for central serous chorioretinopathy. Med Hypotheses. 2013;81(2):268-273. doi: 10.1016/j.mehy.2013.04.032.
59. Behar Cohen F, Zhao M. Corticosteroids and the retina: a role for the mineralocorticoid receptor. Curr Opin Neurol. 2016;29(1):49-54. doi: 10.1097/WCO.0000000000000284.
Review
For citations:
Shaimova V.A., Kravchenko T.G., Arslanov G.M., Shaimov T.B., Shaimov R.B. Psychological Traits of Patients with Central Serous Chorioretinopathy (Literature Review). Ophthalmology in Russia. 2023;20(2):221-227. (In Russ.) https://doi.org/10.18008/1816-5095-2023-2-221-227
Views:
570
Email this article 